CClinicalTrials.gg
CompletedNCT04647565Updated Oct 25, 2021

Alcohol and Women : Screening in General

An observational study in Alcoholism, sponsored by University Hospital, Montpellier. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-10-25.

Sponsored by University Hospital, Montpellier · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
Female
01

Study summary

The alcohol consumption of adults has been decreasing in France since the sixties. When focusing on the particular case of women, this trend goes on the opposite direction. In addition, the impact of drinking alcohol involves an increased severity in women in comparison to men. Furthermore, women consult less often doctors about their alcohol problem due to stigmatisation. Finally, as alcohol consumption is a major public health issue (second preventable cause of death), the aim of this study is to propose an earlier screening of women with alcohol use disorders (AUD) in general medicine.

Read the detailed description

To improve the screening of women with AUD in general médicine, from their perceptions and experiences, and to create a screening tool to general practitioners.

The chosen method is a qualtitative study through semi-structured interview with women with AUD.

A qualitative assessment of these individual interviews could show various topics.

02

Conditions studied

  • Alcoholism

Browse trials for

Keywords

  • women reporting alcohol abuse and/or dependence
  • women recruted during hospitalisation and/or consultation
  • Alcohol
03

In context

Alcoholism

1,606 studies on the registry are indexed under Alcoholism; 329 are open to participants now.

This study's enrollment of 20 is below the median of 180 across 173 observational studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Over 18 years old alcoholic womens, medical caring in consultation with addictologist or in hospitalisation for withdrawal.

Inclusion criteria

  • over 18 years old alcoholic women, with one or several addiction, from all social class.

Exclusion criteria

Exclusion criteria:

  • not being able to answer the questionnaire
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Interventions

  • Otherinterviews

    interviews (human and social sciences)

06

What researchers measure

Primary outcomes

  1. Assessment of women's opinion on an alcoholism screening by general practitioners.

    Assessment of women's opinion on an alcoholism screening by general practitioners : Qualitative study based on semi-structured interview with women with AUD.

    Time frame: 1 year

  2. Creation of a screening tool dedicated to general practitioners

    Creation of a screening tool dedicated to general practitioners : Built of a screening tool based both on litterature review about alcohol \& women and a qualitative study on women's opinion.

    Time frame: 1 year

07

Study locations

1 site
  • Uhmontpellier
    Montpellier, 34295, France
08

References and documents

Individual participant data

Plan to share: Undecided — NC

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04647565
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Dec 1, 2020
Start date
Dec 1, 2020
Primary completion
Jun 30, 2021
Completion
Jun 30, 2021
Last update
Oct 25, 2021

Study contacts

Claire MONTADE
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion